A treatment strategy for KRAS-driven tumors Journal Article

  


Authors: Mai, T. T.; Lito, P.
Article Title: A treatment strategy for KRAS-driven tumors
Abstract: Studies in KRAS-mutant lung and pancreatic adenocarcinoma and in KRAS-amplified gastric carcinoma reveal that SHP2 inhibition augments the antitumor effect of MEK inhibitor treatment. © 2018 The Publisher.
Journal Title: Nature Medicine
Volume: 24
Issue: 7
ISSN: 1078-8956
Publisher: Nature Publishing Group  
Date Published: 2018-07-01
Start Page: 902
End Page: 904
Language: English
DOI: 10.1038/s41591-018-0111-x
PROVIDER: scopus
PUBMED: 29988139
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049751537&doi=10.1038%2fs41591-018-0111-x&partnerID=40&md5=abd5691e81b4c6c63861dee670d27158
Notes: Review -- Export Date: 1 August 2018 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Piro Lito
    58 Lito
  2. Thi Trang Mai
    6 Mai
Related MSK Work